Portage Biotech Inc.
PRTG
$9.11
$0.252.82%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.67M | 1.67M | 1.76M | 3.33M | 5.03M |
| Total Receivables | 12.00K | 12.00K | 570.00K | 23.00K | 39.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 475.00K | 475.00K | 275.00K | 1.78M | 2.56M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 68.00K | 68.00K | 77.00K | 63.00K | 64.00K |
| Total Current Assets | 2.23M | 2.23M | 2.69M | 5.20M | 7.70M |
|
|
|||||
| Total Current Assets | 2.23M | 2.23M | 2.69M | 5.20M | 7.70M |
| Net Property, Plant & Equipment | -- | -- | 20.00K | 27.00K | 35.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | 14.00K | 49.00K |
| Total Assets | 2.23M | 2.23M | 2.71M | 5.24M | 7.78M |
|
|
|||||
| Total Accounts Payable | 427.00K | 427.00K | 221.00K | 1.56M | 482.00K |
| Total Accrued Expenses | 660.00K | 660.00K | 588.00K | 1.31M | 2.31M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | 28.00K | 37.00K | 40.00K |
| Total Finance Division Other Current Liabilities | 13.00K | 13.00K | 36.00K | 98.00K | 46.00K |
| Total Other Current Liabilities | 13.00K | 13.00K | 36.00K | 98.00K | 46.00K |
| Total Current Liabilities | 1.10M | 1.10M | 873.00K | 3.01M | 2.88M |
|
|
|||||
| Total Current Liabilities | 1.10M | 1.10M | 873.00K | 3.01M | 2.88M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | 7.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1.95M | 1.95M | 1.14M | 422.00K | 1.56M |
| Total Liabilities | 3.05M | 3.05M | 2.01M | 3.43M | 4.45M |
|
|
|||||
| Common Stock & APIC | 221.80M | 221.80M | 219.61M | 219.50M | 219.50M |
| Retained Earnings | -245.45M | -245.45M | -242.33M | -240.97M | -239.32M |
| Treasury Stock & Other | 23.53M | 23.53M | 24.13M | 23.99M | 23.84M |
| Total Common Equity | -123.00K | -123.00K | 1.40M | 2.51M | 4.02M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -123.00K | -123.00K | 1.40M | 2.51M | 4.02M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -704.00K | -704.00K | -703.00K | -701.00K | -693.00K |
| Total Equity | -827.00K | -827.00K | 695.00K | 1.81M | 3.33M |
|
|
|||||